-
公开(公告)号:PL298705A1
公开(公告)日:1994-04-18
申请号:PL29870593
申请日:1993-04-26
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: C07D491/12 , C07D491/22
-
公开(公告)号:CZ9203237A3
公开(公告)日:1993-10-13
申请号:CS323792
申请日:1992-10-27
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/47 , A61K31/435 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22
CPC classification number: C07D319/18 , C07D317/66
-
公开(公告)号:ZA928324B
公开(公告)日:1993-05-04
申请号:ZA928324
申请日:1992-10-28
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K20060101 , C07D20060101 , C07D , A61K
-
公开(公告)号:NO924158A
公开(公告)日:1993-04-30
申请号:NO924158
申请日:1992-10-28
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/47 , A61K31/435 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22
CPC classification number: C07D319/18 , C07D317/66
-
公开(公告)号:AU1231492A
公开(公告)日:1992-08-27
申请号:AU1231492
申请日:1992-01-24
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL J , BESTERMAN JEFFREY M , EVANS MICHAEL G , ROSS JOHNSON M
IPC: C07D491/04 , C07D491/056 , A61K31/47
Abstract: The present invention relates to the compounds of formula (I), wherein: R is hydrogen, hydroxy or amino; R is hydrogen, hydroxy, methoxy or methoxymethoxy; R is hydrogen, hydroxy, amino, methoxy, methoxymethoxy or, taken together with R , methylenedioxy (also known as 1,3 dioxolo); R is hydrogen, hydroxy, methoxy, methoxymethoxy, benzyl, di(C1-4)alkylaminomethyl or, taken together with R , methylenedioxy; R is hydrogen or hydroxy; provided that at least one of R through R is other than hydrogen; and i) X is hydroxy or methoxy with X , X and X being hydrogen; or ii) X taken together with X , X taken together with X or X taken together with X , is methylenedioxy, provided that each of the remaining respective X , X , X and X substituents are hydrogen, intermediates in the synthesis of them, pharmaceutical formulation containing them, their use as inhibitors of topoisomerase and their use in the treatment of tumors.
-
公开(公告)号:SK323792A3
公开(公告)日:1998-09-09
申请号:SK323792
申请日:1992-10-27
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL J , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER L
IPC: A61K31/435 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/47 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22 , A61K31/33
Abstract: The invention relates to water soluble, camptothecin derivatives of formula (I), wherein: n represents the integer 1 or 2; and i) R and R represent independently, hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy lower alkyl; ii) R represents hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl or lower alkoxy lower alkyl, and R represents -COR wherein R represents hydrogen, lower alkyl, perhalo-lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl; or iii) R and R taken together with the linking nitrogen form a saturated 3 to 7 atom heterocyclic group of formula (IA) wherein: Y represents O, S, CH , NR4 wherein R4 represents hydrogen, lower alkyl, perhalo-lower alkyl, aryl, aryl substituted with one or more lower alkyl, halogen, nitro, amino, lower alkyl amino, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl groups or; -COR5 wherein R5 represents hydrogen, lower alkyl, perhalo-lower alkyl, lower alkoxy, aryl, aryl substituted with one or more lower alkyl, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups; and the pharmaceutically acceptable salts thereof; their use in the treatment of tumors and methods of their preparation.
-
公开(公告)号:CZ284023B6
公开(公告)日:1998-07-15
申请号:CS323792
申请日:1992-10-27
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/47 , A61K31/435 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22
Abstract: The invention relates to water soluble, camptothecin derivatives of formula (I), wherein: n represents the integer 1 or 2; and i) R and R represent independently, hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy lower alkyl; ii) R represents hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl or lower alkoxy lower alkyl, and R represents -COR wherein R represents hydrogen, lower alkyl, perhalo-lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl; or iii) R and R taken together with the linking nitrogen form a saturated 3 to 7 atom heterocyclic group of formula (IA) wherein: Y represents O, S, CH , NR4 wherein R4 represents hydrogen, lower alkyl, perhalo-lower alkyl, aryl, aryl substituted with one or more lower alkyl, halogen, nitro, amino, lower alkyl amino, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl groups or; -COR5 wherein R5 represents hydrogen, lower alkyl, perhalo-lower alkyl, lower alkoxy, aryl, aryl substituted with one or more lower alkyl, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups; and the pharmaceutically acceptable salts thereof; their use in the treatment of tumors and methods of their preparation.
-
公开(公告)号:PL173684B1
公开(公告)日:1998-04-30
申请号:PL29870593
申请日:1993-04-26
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL J , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER L
IPC: C07D491/12 , C07D491/22
-
公开(公告)号:NO924158L
公开(公告)日:1993-04-30
申请号:NO924158
申请日:1992-10-28
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL JOSEPH , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER LESLIE
IPC: A61K31/435 , A61K31/4738 , A61K31/47 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22
Abstract: The invention relates to water soluble, camptothecin derivatives of formula (I), wherein: n represents the integer 1 or 2; and i) R and R represent independently, hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy lower alkyl; ii) R represents hydrogen, lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl or lower alkoxy lower alkyl, and R represents -COR wherein R represents hydrogen, lower alkyl, perhalo-lower alkyl, (C PI 1/2 )cycloalkyl, (C PI 1/2 )cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl; or iii) R and R taken together with the linking nitrogen form a saturated 3 to 7 atom heterocyclic group of formula (IA) wherein: Y represents O, S, CH , NR4 wherein R4 represents hydrogen, lower alkyl, perhalo-lower alkyl, aryl, aryl substituted with one or more lower alkyl, halogen, nitro, amino, lower alkyl amino, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl groups or; -COR5 wherein R5 represents hydrogen, lower alkyl, perhalo-lower alkyl, lower alkoxy, aryl, aryl substituted with one or more lower alkyl, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups; and the pharmaceutically acceptable salts thereof; their use in the treatment of tumors and methods of their preparation.
-
公开(公告)号:CA2081580A1
公开(公告)日:1993-04-30
申请号:CA2081580
申请日:1992-10-28
Applicant: GLAXO INC
Inventor: LUZZIO MICHAEL J , BESTERMAN JEFFREY M , EVANS MICHAEL G , MYERS PETER L
IPC: A61K31/47 , A61K31/435 , A61K31/4738 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K31/541 , A61P35/00 , A61P43/00 , C07D317/66 , C07D319/18 , C07D491/22 , C07D498/22 , C07D405/06 , C07D413/06 , C07D417/06 , A61K31/495 , A61K31/535 , A61K31/54
Abstract: GLX-76/AC155 WATER SOLUBLE CAMPTOTHECIN DERIVATIVES The invention relates to water soluble, camptothecin derivatives of formula (1), (I) wherein: n represents the integer 1 or 2; and i) R1 and R2 represent independently, hydrogen, lower alkyl, (C3 7)cycloalkyl;(C3-7)cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy lower alkyl; ii) R1 represents hydrogen, lower alkyl, (C3-7)cycloalkyl, (C3-7)cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl or lower alkoxy lower alkyl, and R2 represents -COR3 wherein R3 represents hydrogen, lower alkyl, perhalo-lower alkyl, (C3-7)cycloalkyl, (C3-7)cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl; or iii) R1 and R2 taken together with the linking nitrogen form a saturated 3 to 7 atom heterocyclic group of formula (IA) wherein: Y represents O, S, CH2, NR4 wherein R4 represents hydrogen, lower alkyl, perhalo-lower alkyl, aryl, aryl substituted with one or more lower alkyl, halogen, nitro, amino, lower alkyl amino, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl groups or; -COR5 wherein R5 represents hydrogen, lower alkyl, perhalo-lower alkyl, lower alkoxy, aryl, aryl substituted with one or more lower alkyl, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups; and the pharmaceutically acceptable salts thereof; their use in the treatment of tumors and methods of their preparation.
-
-
-
-
-
-
-
-
-